Mr William Collins > Goodwin > Boston, United States > Lawyer Profile

United States




William Collins is a partner in Goodwin’s nationally recognized Life Sciences group, counseling clients in the industries of biotechnology, pharmaceuticals and medical devices. Serving as his clients’ general or principal outside counsel, Mr. Collins provides strategic advice and general corporate counseling to management teams and boards while leading significant transactions on his clients’ behalf.

Mr. Collins has extensive experience with startup and formation matters, venture capital financing, initial public offerings and capital markets transactions, acquisitions and purchase option agreements, strategic collaborations, and other complex transactions. He also represents a number of publicly traded biotechnology companies in ongoing SEC compliance and corporate governance matters. Advising companies throughout the full range of the corporate life cycle, Mr. Collins has worked with many of his company-side clients since their initial founding and funding. He joined Goodwin in 2010.


J.D., 2009 Boston University School of Law (cum laude) B.S., 2006 The University of Texas at Dallas (cum laude)

Lawyer Rankings

United States > M&A/corporate and commercial > Venture capital and emerging companies

(Next Generation Partners)

William CollinsGoodwin

Goodwin has an excellent track record for representing companies and investors throughout all stages of the venture life cycle. The firm’s Boston team is especially noted for its support to clients in the life sciences sector, where it is ‘one of the most respected, most experienced, best staffed, and best equipped‘ firms in the market. This is complemented by good credentials in the technology space which has seen growth in mobility tech, robotics, edtech and blockchain-related work, and where partners such as John Egan and Kenneth Gordon in Boston, and Anthony McCusker in Silicon Valley hold sway. Boston-based partners Mitchell Bloom and Kingsley Taft co-chair the life sciences side of the practice, which benefits from the expertise of partners such as William Collins and the versatile and ‘highly knowledgeableWilliam Schnoor, who is ‘one of the most experienced venture/ biotech lawyers in the industry‘ and also handles technology-related matters.